基于树突状细胞的肿瘤疫苗接种是否应纳入新诊断胶质母细胞瘤患者的标准治疗中？ - Suppr

Suppr

超能文献

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?

作者信息

Van Gool Stefaan, De Vleeschouwer Steven

出版信息

Expert Rev Neurother. 2012 Oct;12(10):1173-6. doi: 10.1586/ern.12.107.

DOI:10.1586/ern.12.107

PMID:23082731

Abstract

摘要

相似文献

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?

Expert Rev Neurother. 2012 Oct;12(10):1173-6. doi: 10.1586/ern.12.107.

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Cancer Res. 2001 Feb 1;61(3):842-7.

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.

Cancer Res. 2004 Jul 15;64(14):4973-9. doi: 10.1158/0008-5472.CAN-03-3505.

[II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma].

Gan To Kagaku Ryoho. 2015 Jun;42(6):683-6.

Dendritic cell vaccines to combat glioblastoma.

Expert Rev Neurother. 2010 Apr;10(4):483-6. doi: 10.1586/ern.10.26.

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.

Expert Opin Biol Ther. 2015 Jan;15(1):79-94. doi: 10.1517/14712598.2015.972361. Epub 2014 Oct 18.

Mechanisms of immunomodulation in human glioblastoma.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39.

DCVax®-L--developed by Northwest Biotherapeutics.

Hum Vaccin Immunother. 2014;10(11):3139-45. doi: 10.4161/hv.29276.

Dendritic cell immunotherapy for glioblastoma.

Expert Rev Anticancer Ther. 2014 Jul;14(7):761-3. doi: 10.1586/14737140.2014.921571. Epub 2014 May 21.

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Semin Immunopathol. 2017 Feb;39(2):225-239. doi: 10.1007/s00281-016-0616-7. Epub 2017 Jan 30.

引用本文的文献

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Transl Cancer Res. 2023 Aug 31;12(8):2224-2228. doi: 10.21037/tcr-23-603. Epub 2023 Jul 28.

Brain Tumor Immunotherapy: What have We Learned so Far?

Front Oncol. 2015 Jun 17;5:98. doi: 10.3389/fonc.2015.00098. eCollection 2015.

Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis.

PLoS One. 2014 Sep 12;9(9):e107173. doi: 10.1371/journal.pone.0107173. eCollection 2014.

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Cancers (Basel). 2013 Aug 14;5(3):1020-48. doi: 10.3390/cancers5031020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?

作者信息

Van Gool Stefaan, De Vleeschouwer Steven

出版信息

Expert Rev Neurother. 2012 Oct;12(10):1173-6. doi: 10.1586/ern.12.107.

DOI:10.1586/ern.12.107

PMID:23082731

Abstract

摘要

相似文献

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?

Expert Rev Neurother. 2012 Oct;12(10):1173-6. doi: 10.1586/ern.12.107.

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Cancer Res. 2001 Feb 1;61(3):842-7.

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.

Cancer Res. 2004 Jul 15;64(14):4973-9. doi: 10.1158/0008-5472.CAN-03-3505.

[II. Autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma].

Gan To Kagaku Ryoho. 2015 Jun;42(6):683-6.

Dendritic cell vaccines to combat glioblastoma.

Expert Rev Neurother. 2010 Apr;10(4):483-6. doi: 10.1586/ern.10.26.

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.

Expert Opin Biol Ther. 2015 Jan;15(1):79-94. doi: 10.1517/14712598.2015.972361. Epub 2014 Oct 18.

Mechanisms of immunomodulation in human glioblastoma.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39.

DCVax®-L--developed by Northwest Biotherapeutics.

Hum Vaccin Immunother. 2014;10(11):3139-45. doi: 10.4161/hv.29276.

Dendritic cell immunotherapy for glioblastoma.

Expert Rev Anticancer Ther. 2014 Jul;14(7):761-3. doi: 10.1586/14737140.2014.921571. Epub 2014 May 21.

The development of dendritic cell vaccine-based immunotherapies for glioblastoma.

Semin Immunopathol. 2017 Feb;39(2):225-239. doi: 10.1007/s00281-016-0616-7. Epub 2017 Jan 30.

引用本文的文献

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Transl Cancer Res. 2023 Aug 31;12(8):2224-2228. doi: 10.21037/tcr-23-603. Epub 2023 Jul 28.

Brain Tumor Immunotherapy: What have We Learned so Far?

Front Oncol. 2015 Jun 17;5:98. doi: 10.3389/fonc.2015.00098. eCollection 2015.

Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis.

PLoS One. 2014 Sep 12;9(9):e107173. doi: 10.1371/journal.pone.0107173. eCollection 2014.

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Cancers (Basel). 2013 Aug 14;5(3):1020-48. doi: 10.3390/cancers5031020.